Skip to main content
. 2022 Nov 24;55:101747. doi: 10.1016/j.eclinm.2022.101747

Fig. 2.

Fig. 2

SROC curves for PDAC vs healthy controls (A) and PDAC vs benign disease (B). SROC curves are truncated at their respective maximal and minimal observed specificities. Extrapolation beyond these regions is indicated by the dashed lines. 95% CrI, 95% credible interval; AUC, area under the summary receiver operating characteristic (SROC) curve; BD, benign pancreatic diseases; HC, healthy controls; N, number of studies; PDAC, pancreatic ductal adenocarcinoma.